FDA.reportPublic FDA data

sirolimus 100 MG Injection

RxCUI
2586863
RxNorm name
sirolimus 100 MG Injection
Display name
sirolimus 100 MG Injection
Full name
sirolimus 100 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f9bb784-53e2-46f9-a65d-1c6c2a230eafsirolimus 100 MG Injection [PSN] · sirolimus 100 MG Injection [SCD]29These highlights do not include all the information needed to use FYARRO safely and effectively. See full prescribing information for FYARRO. FYARRO ® (sirolimus protein-bound particles for injectable suspension) (albumin-bound), for intravenous use Initial U.S. Approval: 202120260519